make FDA OKs Ranbaxy New Jersey plant generic Diovan
use planned Both the active pharmaceutical (API) and formulation plants in India that Ranbaxy Laboratories long delayed produce generic version of Novartis ($ NVS) blood pressure drug Diovan are under FDA Import Alerts. But the Indian …
Read more at FiercePharma Production code

Another One Bites the Dust: Diovan patent has expired, but general valsartan Is MIA
Although the patent on valsartan (Diovan, Novartis) has expired last Friday, has to make a generic version of the popular antihypertensive still on the market. In contrast, a generic version of Diovan HCT, a combination of valsartan and …
Read more at Forbes

Sandoz Launches Generic Diovan in the U.S.
This launch follows the Sandoz U.S. introduction of an authorized generic version of Diovan HCT (valsartan and hydrochlorothiazide) in 2012. Both Diovan and Diovan HCT are marketed in the United States by Novartis Pharmaceuticals Corp. and are …
Read more on Drug Discovery & Development